Allergan CEO Brent Saunders and chief legal officer Bob Bailey explained in a recent interview, that they are being forced to have to protect their patents against what the company considers to be “double jeopardy” in patent disputes.

Should pharmaceutical companies be subjected to double jeopardy? The Fifth Amendment of the United States Constitution provides